MENU
FI | EUR
-
-
-
-
- Forum Labo 2025
- Advanced Therapies Week (ATW) 2025
- SLAS Europe 2025
- Medlab Middle East 2025
- Biologics World Nordics 2025
- Bioprocessing Summit Europe 2025
- BioProcess International Europe 2025
- ASIA LABEX: The Lab Show 2025
- SLAS International 2025
- ISEV 2025
- Future Labs Live 2025
- DataHow Symposium 2025
- Cell 2025
-
-
-
-
- Forum Labo 2025
- Advanced Therapies Week (ATW) 2025
- SLAS Europe 2025
- Medlab Middle East 2025
- Biologics World Nordics 2025
- Bioprocessing Summit Europe 2025
- BioProcess International Europe 2025
- ASIA LABEX: The Lab Show 2025
- SLAS International 2025
- ISEV 2025
- Future Labs Live 2025
- DataHow Symposium 2025
- Cell 2025
FI | EUR
-
- Benchtop Centrifuges
- Floor-Standing Centrifuges
- Refrigerated Centrifuges
- Microcentrifuges
- Multipurpose Centrifuges
- High-Speed Centrifuges
- Ultracentrifuges
- Concentrator
- IVD Products
- High-Speed and Ultracentrifuge Consumables
- Centrifuge Tubes
- Centrifuge Plates
- Device Management Software
- Sample and Information Management
-
- All Pipettes, Dispensers & Automated Liquid Handlers
- Mechanical Pipettes
- Electronic Pipettes
- Multi-Channel Pipettes
- Positive Displacement Pipettes & Dispensers
- Automated Pipetting
- Bottle-Top Dispensers
- Pipette Controllers
- Pipette Tips
- Automation Consumables
- Dispenser & Pipette Accessories
- Automation Accessories
No results found
Search Suggestions

Webinar
Optimizing a Biosimilar Production Process
Lab Academy
- Pharma
- Bioprocessing
- Cell Culture
- Bioprocess
- Recorded Webinars
The global market for biosimilars is expected to reach US$25 bn by 2020, when more than ten global blockbuster biopharmaceuticals, with sales of more than US$67 bn, will be off-patent. Many of these drugs are human or humanized monoclonal antibodies (hMAbs).
The objective of the research project presented in this webinar was to determine if the three primary methods of production for a typical biosimilar (batch, fed-batch, and perfusion) may be simply and easily executed using a single, benchtop bioprocess control system to allow confident process decisions that are scalable to full production. We compared two perfusion processes. For the fed-batch and perfusion cultivations, we used stirred-tank single-use bioreactors.
This webinar will discuss the outcome of these studies, and will provide an analysis of the benefits of their respective usage in biosimilar production with a particular focus on improving time and cost efficiency.
This webinar took place on Tuesday June 14th 2016
This webinar will discuss the outcome of these studies, and will provide an analysis of the benefits of their respective usage in biosimilar production with a particular focus on improving time and cost efficiency.
This webinar took place on Tuesday June 14th 2016
Read more
Read less
Register and watch recording now!
Read more
Read less